PMID: 6540399Sep 1, 1984Paper

Control of on/off phenomenon by continuous intravenous infusion of levodopa

Neurology
N QuinnC D Marsden

Abstract

In 10 parkinsonian patients with severe, chaotic clinical response fluctuations, oral levodopa treatment was replaced by continuous intravenous infusion of levodopa (with orally administered benserazide). Four patients were also given levodopa infusions in addition to their usual oral treatment. All patients remained continuously mobile and ambulant during the infusions. Side effects were minimal, except in two patients with diphasic dyskinesias whose abnormal movements were consistently suppressed by a further increase in the rate of levodopa administration, only to return after an interval. If a soluble nonacidic dopamine replacement drug can be developed for continuous subcutaneous infusion, "brittle" parkinsonians may be chronically controlled by portable, minipump technology.

Citations

Jan 14, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·L V MetmanT N Chase
Dec 1, 1989·Annals of Neurology·M K HorneG A Brazenor
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·R HardoffN Giladi
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·J VaamondeJ A Obeso
Jan 1, 1992·Movement Disorders : Official Journal of the Movement Disorder Society·F StocchiA Agnoli
Apr 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·J G NuttS T Gancher
Mar 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·S RoseC D Marsden
May 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·T L DavisR S Burns
Sep 26, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·R PahwaW C Koller
Dec 17, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·L A SmithC D Marsden
Oct 2, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·V P CalabreseD Sica
Jan 1, 1990·European Journal of Clinical Pharmacology·E BredbergL Paalzow
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·B Kleedorfer, W Poewe
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·A HeinzH Przuntek
Aug 1, 1989·Italian Journal of Neurological Sciences·T CaraceniA Lorizio
Nov 19, 2008·Journal of Neurology·Francesca Del Sorbo, Alberto Albanese
Nov 26, 2010·Journal of Neurology·Manuela Contin, Paolo Martinelli
Dec 2, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Phylinda L S ChanNicholas H G Holford
Jan 1, 1987·Pharmacology & Therapeutics·A E Lang
Jun 6, 2000·Advanced Drug Delivery Reviews·L Själander-Brynne, L K Paalzow
Jun 8, 2001·Clinical Neuropharmacology·L V MetmanT N Chase
Jun 11, 2004·Clinical Neuropharmacology·Alessandra MongeGianpietro Nordera
Dec 17, 2004·Clinical Neuropharmacology·Dag Nyholm, Sten-Magnus Aquilonius
Dec 14, 2011·The Neurologist·Maria Cruz Rodriguez-OrozOriol de Fabregues
Jan 1, 1990·British Journal of Clinical Pharmacology·D R RobertsonC F George
Aug 1, 1991·Australian and New Zealand Journal of Medicine·M T BullingR J Burns

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.